Scaling-up biodegradable nanomedicines for multimodal precision cancer immunotherapy

Recent Posts

First Patient Dosed in PRECIOUS-01 Study of PORT-3 for the Treatment of NY-ESO-1 Positive Solid Tumors 07/04/2021
H2020 funded ‘PRECIOUS’ clinical trial has kicked off since February 2021 18/03/2021
PRECIOUS will revolutionise cancer treatment 20/09/2016
€8.3 million EU grant awarded to international ‘PRECIOUS’ consortium to integrate nanomedicines and immunotherapy to attack cancer 19/09/2016

Search for:

OUR PARTNERS